| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |